Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells.
Nature biomedical engineering
View this publicationNature biomedical engineering
View this publicationPathogens (Basel, Switzerland)
View this publicationDevelopmental cell
View this publicationPublication categories: Top publication
Kidney international
View this publicationEuropean urology
View this publicationPneumologie (Stuttgart, Germany)
View this publicationJournal of neurochemistry
View this publicationPloS one
View this publicationAmerican journal of clinical dermatology
View this publicationClinical and translational gastroenterology
View this publication